FUJIFILM Biotechnologies Expands Partnership with argenx to Include U.S. Manufacturing

Read more

Roche to Acquire 89bio in Merger Deal, Gaining Phase 3 MASH Therapy Candidate

Read more

Biogen’s ZURZUVAE Approved in Europe as First Treatment for Postpartum Depression

Read more

VectorY and Shape Therapeutics Partner to Develop AAV5-Based Vectorized Antibodies for Neurodegenerative Diseases

Read more

Wheeler Bio and MindImmune Therapeutics Partner to Support Alzheimer’s Prevention Program MITI-101

Read more

Novo Nordisk’s Oral Semaglutide Yields 16.6% Weight Loss in Obesity Study

Read more

GSK to Invest $30 Billion in U.S. R&D and Manufacturing Over Next 5 Years

Read more

Mabwell and Aditum Bio Launch Kalexo Bio to Develop siRNA Cardiovascular Therapies

Read more

Adagene and Exelixis Expand SAFEbody Collaboration to Develop Third Masked Antibody-Drug Conjugate

Read more

Reunion Neuroscience Closes Series A, Advances RE104 for Generalized Anxiety Disorder

Read more